Cart
sales@molnova.com
Sulfacetamide sodium salt hydrate
CAS No. 6209-17-2
Sulfacetamide sodium salt hydrate( —— )
Catalog No. M15350 CAS No. 6209-17-2
Sulfacetamide sodium monohydrate is a sulfonamide antibiotic, has been investigated for use in the treatment of pityriasis versicolor and rosacea.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 27 | In Stock |
|
| 100MG | 47 | In Stock |
|
| 200MG | 77 | In Stock |
|
| 500MG | 128 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSulfacetamide sodium salt hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSulfacetamide sodium monohydrate is a sulfonamide antibiotic, has been investigated for use in the treatment of pityriasis versicolor and rosacea.
-
DescriptionSulfacetamide sodium monohydrate is a sulfonamide antibiotic, has been investigated for use in the treatment of pityriasis versicolor and rosacea.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorDHPS
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number6209-17-2
-
Formula Weight254.2
-
Molecular FormulaC8H9N2NaO3S·H2O
-
Purity>98% (HPLC)
-
SolubilitySoluble in Water
-
SMILESO.[Na].CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hevener KE, et al. J Chem Inf Model. 2009 Jan 27.
molnova catalog
related products
-
AUTEN-67
A small molecule autophagy enhancer that specificly inhibits myotubularin-related phosphatase MTMR14; at concentrations of 2, 10, and 100 uM, AUTEN-67 inhibits MTMR14 by nearly 3%, 25%, and 70%, respectively.
-
PD146176
PD146176 is an inhibitor of 15-Lipoxygenase (15-LO) , it inhibits rabbit reticulocyte 15-LO with Ki of 197 nM and IC50 of 0.54 μM.?PD146176 reverses cognitive impairment, brain amyloidosis, and tau pathology by stimulating autophagy in aged triple transgenic mice.
-
STO-609 acetate
STO-609 acetate is selective, cell-permeable inhibitor of Ca2+-calmodulin-dependent protein kinase kinase (Ki: 80/15 ng/ml, for CaM-KKα/KKβ); competes for the ATP-binding site.
